Institute of Human Genetics, Saarland University, Building 60, 66421, Homburg, Germany.
Institute of Virology and Center of Human and Molecular Biology, Saarland University, 66421, Homburg, Germany.
J Immunother Cancer. 2019 Jul 16;7(1):187. doi: 10.1186/s40425-019-0670-5.
Micro(mi)RNAs are increasingly recognized as central regulators of immune cell function. While it has been predicted that miRNAs have multiple targets, the majority of these predictions still await experimental confirmation. Here, miR-34a, a well-known tumor suppressor, is analyzed for targeting genes involved in immune system processes of leucocytes.
Using an in-silico approach, we combined miRNA target prediction with GeneTrail2, a web tool for Multi-omics enrichment analysis, to identify miR-34a target genes, which are involved in the immune system process subcategory of Gene Ontology.
Out of the 193 predicted target genes in this subcategory we experimentally tested 22 target genes and confirmed binding of miR-34a to 14 target genes including VAMP2, IKBKE, MYH9, MARCH8, KLRK1, CD11A, TRAFD1, CCR1, PYDC1, PRF1, PIK3R2, PIK3CD, AP1B1, and ADAM10 by dual luciferase assays. By transfecting Jurkat, primary CD4 and CD8 T cells with miR-34a, we demonstrated that ectopic expression of miR-34a leads to reduced levels of endogenous VAMP2 and CD11A, which are central to the analyzed subcategories. Functional downstream analysis of miR-34a over-expression in activated CD8 T cells exhibits a distinct decrease of PRF1 secretion.
By simultaneous targeting of 14 mRNAs miR-34a acts as major hub of T cell regulatory networks suggesting to utilize miR-34a as target of intervention towards a modulation of the immune responsiveness of T-cells in a broad tumor context.
Micro(mi)RNAs 被越来越多地认为是免疫细胞功能的核心调节剂。虽然已经预测 miRNA 有多个靶标,但这些预测中的大多数仍有待实验证实。在这里,我们分析了已知的肿瘤抑制因子 miR-34a,以确定其在白细胞免疫系统过程中涉及的靶基因。
我们使用一种基于计算机的方法,将 miRNA 靶标预测与 GeneTrail2 相结合,GeneTrail2 是一种用于多组学富集分析的网络工具,以确定参与基因本体论免疫过程亚类的 miR-34a 靶基因。
在这个亚类的 193 个预测靶基因中,我们实验测试了 22 个靶基因,并通过双荧光素酶报告基因实验证实 miR-34a 与 14 个靶基因结合,包括 VAMP2、IKBKE、MYH9、MARCH8、KLRK1、CD11A、TRAFD1、CCR1、PYDC1、PRF1、PIK3R2、PIK3CD、AP1B1 和 ADAM10。通过转染 Jurkat、原代 CD4 和 CD8 T 细胞,我们证明了 miR-34a 的异位表达导致内源性 VAMP2 和 CD11A 的水平降低,这对分析的亚类至关重要。在激活的 CD8 T 细胞中过表达 miR-34a 的功能下游分析显示 PRF1 分泌明显减少。
miR-34a 通过同时靶向 14 个 mRNA 作为 T 细胞调节网络的主要枢纽,表明可以利用 miR-34a 作为干预靶点,以调节广泛肿瘤背景下 T 细胞的免疫反应性。